ISSN 0564-3783  



Main page
Contacts
Preview papers  
Themes
Contents  
Themes
Subscription
Information to authors
Editorial board
Mobile version


In Russian

Export citations
UNIMARC
BibTeX
RIS





Inhibiting effect of agmatine on genetically programmed death of leukocytes in experimental diabetes mellitus

Ferents I.V., Brodyak I.V., Lyuta M.Ya., Burda V.A., Sybirna N.O.

 




SUMMARY. This study is an attempt to elucidate of agmatine effects upon leukocyte apoptosis in experimental diabetes mellitus (EDM). We demonstrated the increase in numbers of the leukocytes with both early and late signs of apoptosis at diabetes. Further changes in the morphofunctional state of the leukocytes include the increased amount of fragmented DNA, elevated apoptotic index and violated ratio of p53 to Bcl-2 proteins. Agmatine has been shown to exert direct corrective effects on leukocyte apoptosis: the content of р53 and Bcl-2 proteins was normalized, apoptotic index was decreased, the process of nuclear DNA degradation was ceased, while the amount of cells with early and late signs of apoptosis was diminished.

Key words: agmatine, leukocytes, apoptosis, experimental diabetes mellitus

Tsitologiya i Genetika 2016, vol. 50, no. 4, pp. 50-61

E-mail: sybirna_natalia yahoo.com

Ferents I.V., Brodyak I.V., Lyuta M.Ya., Burda V.A., Sybirna N.O. Inhibiting effect of agmatine on genetically programmed death of leukocytes in experimental diabetes mellitus, Tsitol Genet., 2016, vol. 50, no. 4, pp. 50-61.

In "Cytology and Genetics":
I. V. Ferents, I. V. Brodyak, M. Ya. Lyuta, V. A. Burda, N. O. Sybirna Suppressive effect of agmatine on genetically programmed death of leukocytes in a diabetes model, Cytol Genet., 2016, vol. 50, no. 4, pp. 241Ц250
DOI: 10.3103/S0095452716040034


Copyright© ICBGE 2002-2017 Coded & Designed by Volodymyr Duplij Modified 20.11.17